(Reuters Health) – Some opioid users are more likely than others to know about and use naloxone, a medication designed to rapidly reverse opioid overdoses, suggests a study conducted in Chicago.
https://www.teleconsulteurope.com/wp-content/uploads/2014/11/teleconsult-logo-300x124.png00Reuters: Health Newshttps://www.teleconsulteurope.com/wp-content/uploads/2014/11/teleconsult-logo-300x124.pngReuters: Health News2018-04-16 21:24:592018-04-16 21:24:59Naloxone-access programs miss many opioid users